What GSI Lab does

GSI Lab (legally PT Genomik Solidaritas Indonesia) is a Jakarta-based medical laboratory founded in 2020 as a social entrepreneurship initiative to expand access to COVID-19 testing in Indonesia. The company operates five drive-thru and walk-in testing centers across the Greater Jakarta region (Cilandak, Kuningan, Cengkareng, Bintaro, and Depok) and offers home and on-site corporate testing services. Its core technology stack is RT-PCR plus rapid antigen and antibody testing, with a proprietary sample-collection innovation called PCR Kumur (#AntiColok), a first-in-Indonesia gargle-based RT-PCR method with reported 93-98% sensitivity. The lab also runs a Whole Genome Sequencing (WGS) capability through its #SolidaritySequence program, the only private laboratory supporting the Indonesian government's SARS-CoV-2 variant surveillance, and has contributed 4,600 WGS samples to the GISAID database.

The business operates on a unit-pricing, pay-as-you-go model across five core products (Swab Antigen at Rp95,000; 24-hour PCR at Rp275,000; PCR Kumur at Rp350,000; S-RBD Quantitative Antibody at Rp249,000; and Same-Day PCR at Rp450,000), distributed through direct-to-consumer channels (walk-in, drive-thru, home service) and an enterprise field sales motion targeting corporate clients such as Kredivo, Shopee, Indika Energy, Petrosea, Kideco, and Mobil. Cumulative outcomes include 700,000+ tests conducted and 6,000+ free PCR tests donated to frontliners and under-served communities, supported by Rp4.4 billion+ in cumulative donations from foundations (Temasek, Tanoto) and corporate sponsors. The company is officially registered as a Laboratorium Jejaring Pemeriksa COVID-19 with the Ministry of Health, integrated with the NAR reporting system and PeduliLindungi app.

In 2023 GSI Lab began extending beyond COVID-19 through the Batik Pelangi rare-disease genomic program (May 2023) and joined Filantropi Indonesia (February 2023), signaling a strategic pivot toward broader molecular diagnostics. Leadership is founder-led under CEO dr. Nino Susanto, with a Senior Research Fellow (PhD) and biomedical engineering staff supporting genomic R&D. Revenue has not been publicly disclosed, and the company remains a privately held social enterprise without documented institutional funding rounds beyond a 2022 investment associated with Alpha JWC Ventures / YCAB Ventures.

Name

GSI Lab

Legal name

PT Genomik Solidaritas Indonesia

Website

https://gsilab.id

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

GSI Lab is a Jakarta-based medical laboratory operating COVID-19 RT-PCR, antigen, and antibody testing across five Greater Jakarta locations, plus corporate on-site services and a government-affiliated whole genome sequencing surveillance program for SARS-CoV-2 variant tracking.

Ownership category

akta.pro rank

Product category

Medical Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN)

Keywords

• COVID-19 PCR testing
• Medical laboratory services
• Antigen rapid testing
• Genomic surveillance services
• Antibody blood testing

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. COVID-19 Testing Services: Direct revenue from providing RT-PCR tests, rapid antigen tests, and antibody tests to individual consumers and corporate clients. Services offered at varying turnaround times and price points.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

GSI Lab operates a private medical laboratory in Greater Jakarta providing COVID-19 testing services — antigen rapid tests, multiple PCR swab turnaround options (same-day and 24-hour), S-RBD quantitative antibody tests, and a proprietary gargle-based PCR (PCR Kumur / #AntiColok). It also runs Whole Genome Sequencing for SARS-CoV-2 variant surveillance and operates donation-funded free testing programs. Services are delivered via drive-thru/walk-in centers, home visits, and corporate on-site testing.

Product overview

GSI Lab (Genomik Solidaritas Indonesia) is a social entrepreneurship initiative providing COVID-19 testing services in Indonesia. The core offering consists of five main testing products: Swab Antigen (rapid test, 30-minute results), PCR Swab Same Day (same-day results), PCR Swab 24-hour (next-day results), S-RBD Quantitative Antibody Test (immunity measurement), and PCR Kumur (gargle-based PCR, #AntiColok innovation). These are delivered through three service channels: Drive/Walk Thru at 5 locations, Home Services for groups, and standard walk-in testing. GSI Lab also operates social programs including free PCR testing for frontliners (#SwabAndSave) and free Whole Genome Sequencing for variant surveillance (#SolidaritySequence). The company is registered as a COVID-19 testing laboratory affiliated with the Indonesian Ministry of Health's NAR system and connects results to the PeduliLindungi government app.

Differentiator

Problem solved

Functional benefit

Products and services

• Swab Antigen Rapid COVID-19 antigen test using nasal swab sample collection. Provides results within 30 minutes. Most affordable testing option at Rp95,000 per test. Targeted at individual consumers and corporate clients needing fast, low-cost screening.
• PCR Swab Same Day Same-day PCR test with results delivered by 23:59 on the same working day. Detects SARS-CoV-2 genetic material using nasal and oral swab sample collection, includes CT values. Most accurate detection method. Priced at Rp450,000 per test.
• PCR Swab 24 jam PCR test with results delivered within 24 hours. Designed for busy customers who can only visit testing centers in the afternoon; results typically received by the next business day. Priced at Rp275,000 per test.
• S-RBD Quantitative Antibody Test Blood test measuring immunity levels against COVID-19 by checking S-RBD antibodies. Helps individuals determine how immune they are against the virus. Priced at Rp249,000 per test.
• PCR Kumur (Gargle PCR / #AntiColok) Pain-free COVID-19 PCR test using gargle sample collection (no nasal/oral swab). First-in-Indonesia innovation with 93-98% sensitivity, branded #NoColok / #AntiColok. Comfortable for children and accepted for flight requirements. Priced at Rp350,000 per test.
• Drive/Walk Thru Testing Contactless drive-thru and walk-in COVID-19 testing service available at 5 Greater Jakarta locations (Cilandak, Kuningan, Cengkareng, Bintaro, and Depok). Minimizes touch contact for a safe and comfortable testing experience and supports rapid 5-minute on-site registration.
• Home Services Mobile COVID-19 testing service where GSI Lab professionals travel to the customer's location. Ideal for testing entire families or office groups who cannot travel to a fixed testing center, including Safety FamTrip packages for families.

Quantifiable outcome

• More than 700,000 tests conducted
• +3 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Partnerships

Two partnerships are on record, tiered minor.

• Oxford UniversityOthersOxford University donated laboratory equipment to GSI Lab, supporting their testing capabilities and infrastructure development.
• YAPPIKA Action AidminorStrategic or Co-development PartnerYAPPIKA Action Aid collaborated with GSI Lab on community health initiatives and social impact programs.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Prodia Widyahusada: Indonesia's largest independent clinical laboratory chain, offering a broad menu of diagnostic tests including PCR and molecular diagnostics. Directly comparable to GSI Lab as a private Indonesian clinical lab competing for corporate and consumer testing volumes.
• Kimia Farma Diagnostika: Subsidiary of state-owned Kimia Farma, operating a nationwide network of clinical laboratories including PCR and COVID-19 testing services. Directly competes with GSI Lab in Indonesian diagnostic testing, particularly for government and corporate clients.
• Pramita Lab: Major Indonesian private clinical laboratory network providing diagnostic testing across Java. Competes with GSI Lab for corporate health screening and outpatient diagnostic volumes.
• Bio Medika: Indonesian clinical laboratory offering PCR, genomic, and routine diagnostic services. Comparable mid-sized private Indonesian lab with similar customer mix including corporate and hospital referrals.
• Biotest (Indonesia): Indonesian clinical laboratory network with PCR and molecular diagnostic capabilities. Comparable private Indonesian lab competing in the same urban corporate and consumer testing market.
• Cito Indonesia (Laboratorium Cito): Established Indonesian clinical laboratory with nationwide branches providing diagnostic and molecular testing. Competes with GSI Lab for corporate clients and broader diagnostic testing volumes in Indonesia.

Broad incumbents

• Natera: US-based specialty molecular diagnostics company with strong PCR/NGS capabilities for reproductive health, oncology, and transplant testing. Comparable as a molecular-diagnostics lab that has built scale on proprietary PCR technology and clinical partnerships.
• Siemens Healthineers (Laboratory Diagnostics): Global diagnostics and laboratory equipment giant supplying PCR instruments and reagents used by labs including GSI Lab. Indirect peer as the infrastructure and assay provider shaping the competitive landscape.

Emerging players

• Color Health: US-based health technology company offering population-scale genetic testing including COVID testing and genomic screening. Comparable emerging player that scaled lab operations around COVID-19 testing and is pivoting toward broader genomics.

Others

• Thermo Fisher Scientific (Clinical Diagnostics): Global supplier of PCR instruments, NGS platforms, and diagnostic reagents used by GSI Lab's laboratory operations. Relevant ecosystem participant that defines GSI Lab's technology and cost structure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCQxphUYcdaV0h8SItgIyJHw
• Facebookfacebook.com/GSILAB.ID
• LinkedInlinkedin.com/company/gsi-lab/?originalSubdomain=id
• Instagraminstagram.com/gsilab.id
• Xx.com/gsilab_id

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GSI Lab